{"id":46007,"date":"2022-07-11T12:02:34","date_gmt":"2022-07-11T10:02:34","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/"},"modified":"2022-07-11T12:02:34","modified_gmt":"2022-07-11T10:02:34","slug":"nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/","title":{"rendered":"NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022"},"content":{"rendered":"
\n

SEATTLE–(BUSINESS WIRE)–#earnings<\/a>–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report second quarter 2022 operating results after the close of the market on Thursday, August 4, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results and provide a business update.\n<\/p>\n

<\/a><\/p>\n

\nInvestors and other interested parties should register for the conference call in advance by visiting https:\/\/investors.nanostring.com\/events-and-presentations\/default.aspx.<\/a> Following registration, an email confirmation will be sent that includes dial-in details and unique conference call codes for entry. Registration is open throughout the call but to ensure connection for the full call, registration in advance is recommended.\n<\/p>\n

\nThe link to the webcast and audio replay will be made available at the Investor Relations website: nanostring.com<\/a>.\n<\/p>\n

\nA replay of the call will be available beginning August 4, 2022, at 7:30pm ET through midnight on August 11, 2022. To access the replay, dial (866) 813-9403 or (929) 458-6194 and reference Conference ID: 426771. The webcast will also be available on the Company\u2019s website for one year following the completion of the call.\n<\/p>\n

\nAbout NanoString Technologies, Inc.<\/b>\n<\/p>\n

\nNanoString Technologies is a leading provider of life science tools for discovery and translational research. The company provides platforms that allow researchers to map the universe of biology. The nCounter\u00ae Analysis System, cited in more than 6,000 peer-reviewed publications, offers a way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision. NanoString\u2019s GeoMx\u00ae Digital Spatial Profiler enables highly multiplexed spatial profiling of RNA and protein targets in various sample types, including FFPE tissue sections, and has been cited in approximately 90 peer-reviewed publications. The CosMx Spatial Molecular Imager, with commercial availability expected in the second half of 2022, enables highly sensitive, high-resolution imaging of hundreds to thousands of RNAs or proteins directly from single cells within morphologically intact whole tissue sections.\n<\/p>\n

\nFor more information, please visit www.nanostring.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nDoug Farrell
\n
Vice President, Investor Relations & Corporate Communications
\n
dfarrell@nanostring.com<\/a>
Phone: 206-602-1768\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SEATTLE–(BUSINESS WIRE)–#earnings–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report second quarter 2022 operating results after the close of the market on Thursday, August 4, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46007","6":"format-standard","7":"category-industry"},"yoast_head":"\nNanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SEATTLE–(BUSINESS WIRE)–#earnings–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report second quarter 2022 operating results after the close of the market on Thursday, August 4, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-11T10:02:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220711005037\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022\",\"datePublished\":\"2022-07-11T10:02:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\\\/\"},\"wordCount\":362,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005037\\\/en\\\/1070856\\\/21\\\/4891105_NSTG_logo_for_Yahoo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\\\/\",\"name\":\"NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005037\\\/en\\\/1070856\\\/21\\\/4891105_NSTG_logo_for_Yahoo.jpg\",\"datePublished\":\"2022-07-11T10:02:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005037\\\/en\\\/1070856\\\/21\\\/4891105_NSTG_logo_for_Yahoo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220711005037\\\/en\\\/1070856\\\/21\\\/4891105_NSTG_logo_for_Yahoo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/","og_locale":"en_US","og_type":"article","og_title":"NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022 - Pharma Trend","og_description":"SEATTLE–(BUSINESS WIRE)–#earnings–NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that the Company will report second quarter 2022 operating results after the close of the market on Thursday, August 4, 2022. Company management will host a conference call beginning at 4:30pm ET to discuss those results ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-11T10:02:34+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220711005037\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022","datePublished":"2022-07-11T10:02:34+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/"},"wordCount":362,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220711005037\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/","url":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/","name":"NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220711005037\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg","datePublished":"2022-07-11T10:02:34+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220711005037\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220711005037\/en\/1070856\/21\/4891105_NSTG_logo_for_Yahoo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/nanostring-to-release-second-quarter-2022-operating-results-and-host-conference-call-on-thursday-august-4-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"NanoString to Release Second Quarter 2022 Operating Results and Host Conference Call on Thursday, August 4, 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46007"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46007\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46007"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46007"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}